POM Sues FTC over New Substantiation Standard for Food and Dietary Supplement Claims
POM Wonderful LLC (“POM”) filed a Complaint against the Federal Trade Commission (“FTC”) on September 13, 2010. POM alleges that the FTC has adopted a “new standard” for substantiation that it is applying against food and dietary supplement companies. The “new standard” is reflected in two recently published consent orders against Nestle USA and Iovate Health Sciences, Inc., in which the FTC prohibits future claims by the companies unless the claims are supported by two well-controlled human clinical studies. The “new standard,” if POM is correct, marks a drastic change in FTC policy regarding substantial of claims.
According to the Complaint, FTC specifically referred POM to the Nestle and Iovate Consent Orders and asserted that the requirements contained in those consent orders constituted the “new standard” that FTC was applying with legal force and effect. POM alleges that the FTC is no longer interpreting present standards or rules by adopting the “new standard” for substantiation, but instead, the FTC has engaged in formal rulemaking without adhering to the process of notice and comment as required by the Administrative Procedures Act.
Furthermore, POM also alleges that the FTC is requiring advertisers to obtain prior Food and Drug Administration (FDA) approval before making certain disease claims about food, beverages, and dietary supplements. Disease claims are health related claims in which a product represents that it treats, mitigates, or prevents disease. According to POM, the FTC is requiring prior FDA approval for disease claims regardless of whether or not the claims are true or supported by competent, reliable scientific evidence. In addition, the FTC is requiring advertisers to conduct two well-controlled clinical studies for non-disease claims. If POMs allegations accurately reflect current FTC policy, these requirements may constitute a violation of the advertisers First Amendment rights and go beyond the authority of the FTC.
For more information on FTC regulations and substantiation requirements, please contact us at contact@fuerstlaw.com.
This entry was posted on Friday, September 24th, 2010 at 2:33 pm and is filed under General.
Tweetback for this post? Add POM Sues FTC over New Substantiation Standard for Food and Dietary Supplement Claims to your tweet.
November 1st, 2010 at 3:40 pm
[...] [...]
December 20th, 2010 at 1:40 pm
[...] a settlement with the Agency, and as POM has brought its own suit against the FTC, in a matter previously reported in our blog, it is likely that this embroiled battle will continue well into the New [...]
March 8th, 2011 at 12:09 pm
[...] to support such claims and the FDA supports this level of substantiation as well. However, as we have reported recently, the food manufacturer, POM Wonderful, LLC, has claimed that the FTC has been utilizing a new [...]
March 19th, 2012 at 11:45 am
[...] (“FTCâ€) regarding the level of substantiation required to support its claims. As we previously reported, on September 13, 2012, POM filed a complaint in court against the FTC alleging that the FTC has [...]
June 20th, 2012 at 6:28 pm
[...] for health related claims. (Our previous reports on the FTC’s efforts can be read here, here, and here.) Such was the case in the Garden of Life [...]
July 19th, 2012 at 2:41 pm
[...] we previously reported, in September 27, 2010, the Federal Trade Commission (“FTCâ€) filed a complaint against POM [...]
October 1st, 2012 at 12:08 pm
[...] we have previously reported (here, here, and here), over the past several years the FTC has attempted to employ and enforce a [...]
October 24th, 2012 at 10:39 am
[...] substantiation for health related claims through consent decrees. As we have previously reported (here, here, here, and here), the FTC has sought to enforce the definition of “competent and reliable [...]
January 22nd, 2013 at 10:51 am
[...] [...]